Press Release: Dynavax : Dynavax Files Preliminary Proxy Statement
Dynavax's Board is Overseeing Record Operational and Financial Performance Outlines Extensive Engagement with Deep Track and...
Read full article »
Dynavax is a biopharmaceutical company that discovers, develops and commercializes novel vaccines for the treatment of cancer.
Read more